长效GnRHa预防卵巢子宫内膜异位症术后复发的疗效被引量：16

Study on efficacy of GnRHa in preventing postoperative recurrence of ovarian endometrioma

导出

摘要目的:探讨卵巢子宫内膜异位症保守手术后辅助促性腺激素释放激素激动剂(GnRHa)治疗对疾病预后的影响。方法:选择因卵巢子宫内膜异位症行保守手术治疗或保守手术联合术后GnRHa巩固治疗的患者293例,根据术后用药情况分为用药组163例和非用药组130例,于治疗后定期随访,观察两组患者治疗后痛经或慢性盆腔疼痛缓解及复发情况、术后受孕情况及术后疾病复发等指标。结果:用药组患者痛经及慢性盆腔痛的症状较之未用药组明显缓解,且疼痛复发率明显低于非用药组(P<0.05);用药组的术后妊娠率高于非用药组(P<0.05);但是对于降低复发风险,两组人群间无明显差异。结论:卵巢子宫内膜异位症术后辅助GnRHa巩固治疗可缓解疾病相关的疼痛症状,提高术后的妊娠率,但不能降低疾病复发风险。 Objective： To investigate the effect of GnRHa on prognosis of ovarian endometriosis after laparoseopic excision. Methods： A total of 293 ovarian endometriosis patients confirmed pathologically were evaluated retrospectively. 163 patients treated with GnRHa after laparoscopic excision were selected as drug group, and 130 cases with no treatment after surgery were selected as non - drug group. The remission rate of relevant symptoms, pregnancy after surgery, recurrence rate of disease were compared between the two groups during periodical follow - up period. Results： The symptom alleviation rate was higher and pain recurrence rate was lower in drug group when comparing with non - drug group. In addition, treatment with GnRHa could induce pregnancy after surgery. However, recurrence rate of disease between the two groups showed no significant difference. Conclusion： Treatment with GnRHa after conservative laparoscopic surgery could improve disease -related pain symptoms and infertility, while no significant difference was observed when analyzed the recur- rence rate.

作者袁明汪雯雯高玲栗妍李天王世宣

机构地区华中科技大学同济医学院附属同济医院妇产科

出处《中国妇幼保健》 CAS 北大核心 2013年第30期5052-5055,共4页 Maternal and Child Health Care of China

基金国家自然科学基金项目〔81000240〕高等学校博士点科研基金〔200804870009〕

关键词卵巢子宫内膜异位症复发促性腺激素释放激素激动剂 Ovarian endometriosis Recurrence GnRH agonist

分类号 R711.71 [医药卫生—妇产科学]

引文网络
相关文献

参考文献9

1Jenkins S,Olive DL,Haney AF. Endometriosis : pathogeneticimplications of the anatomic distribution[ J],Obstet Gyne-col, 1986, 67 (3) : 335 -338.
2Weir E. Endometriosis .. what is the risk of hospital admission,readmission, and major surgical intervention[J]. Minim In-vasive Gynecol, 2005, 12 (6): 486 -493.
3郑彦,赵瑞华.GnRH-a抑制子宫内膜异位症保守术后复发的国外研究进展[J].中国妇幼保健,2010,25(33):4939-4941. 被引量：13
4Divasta AD,Laufer MR. The use of gonadotropin releasinghormone analogues in adolescent and young patients with en-dometriosis [J]. Curr Opin Obstet Gynecol, 2013, 25(4): 287 -292.
5Fatima P. Outcome of pregnancies after inadvertent exposure toGnRH agonist in early pregnancy[ J]. Mymensingh Med J,2011, 20 (2): 303 -307.
6Kikuchi I. Recurrence rate of endometriomas following a laparo-scopic cystectomy[ J]. Acta Obstet Gynecol Scand,2006,85 (9) : 1120-1124.
7Brown JA,Pan,Hart RJ. Gonadotrophin - releasing hormoneanalogues for pain associated with endometriosis[J]. Co-chrane Database Syst Rev, 2010,12: CD008475.
8Bhattacharya SM. Health - related quality of life following surgi-cal menopause and following gonadotrophin - releasing hormoneanalogue - induced pseudomenopause[ J]. Gynecol Endocri-nol, 2009,25 (9) : 621 -623.
9Vercellini P. Waiting for Godot': a common sense approach tothe medical treatment of endometriosis[ J]. Hum Reprod,2011,26 (1) : 3-13.

二级参考文献20

1Gambone JC, Mittman BS, Munro MG, et al. Consensus statement for the management of chronic pelvic pain and endometriosis: proceedings of an expert - panel consensus process [ J] . Fertil Steril, 2002, 78 (5) : 961.
2Byung C J, Joong YL, Chang SS, et al. Impact of GnRH agonist treatment on recurrence of ovarian endometriomas after conservative laparoscopic surgery [J] . Fertil Steril, 2009, 91 (1): 40.
3Jia - Li K, Xiao - Xia W, Miao - Ling N, et al. Efficacy of gonadotrophin - releasing hormone agonist and an extended - interval dosing regimen in the treatment of patients with adenomyosis and endometriosis [J] . Gynecol Obstet Invest, 2010, 69 (2) : 73.
4Jacques D, Paul JD, Bernard H, et al. Equivalence of the 3 - month and 28 - day formulations of triptorelin with regard to achievement and maintenance of medical castration in women with endometriosis [J] . Fertil Steril, 2004, 81 (2) : 297.
5Olive D. Optimizing gonadotropin - releasing hormone agonist therapy in women with endometfiosis [J] . Treat Endocrinol, 2004, 3 (2) : 83.
6Busacca M, Somigliana E, Bianchi S, et al. Postoperative GnRH analogue treatment after conservative surgery for symptomatic endometriosis stage III/IV : a randomized controlled trial [ J] . Hum Reprod, 2001 , 16 (11): 2399.
7Cosson M, Querleu D, Donnez J, et al. Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, muhicenter, randomized study [J] . Fertil Steril, 2002, 77 (4): 684.
8Regidor PA, Regidor M, Schmidt M, et al. Prospective randomized study comparing the GnRH - agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis [ J ]. Gynecol Endocrinol, 2001, 15 (3): 202.
9Giuseppe L, Carmine C, Cristina R., et al. A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III - IVendometriosis [ J] . Euro J Obstet Gynecol Reprod Biol. 2008. 136 (2): 194.
10Vercellini P, Frontino G, Giorgi O, et al. Endometriosis: preoperative and postoperative medical treatment [ J ] . Obstet Gynecol Clin NorthAm, 2003, 30 (1): 163.